Leptin is a mediator of cardiac alteration in obesity, specifically can exert pro-fibrotic and pro-oxidant effects through the activation of PI3k-Akt signaling pathway, and subsequently the activation of TGF-β and connective tissue growth factor (CTGF) [43,44]. Here, CCN2 is linked to obesity disorder.